Answers are grounded in this paper and cite their sources.
Fast-dissolving oral films (FDOFs), also known as orodispersible films (ODFs), are thin polymeric dosage forms designed to disintegrate or dissolve rapidly in the oral cavity, generally without requiring water. These formulations have gained considerable attention as alternatives to conventional tablets, capsules and liquid dosage forms, particularly for individuals who experience difficulty swallowing solid medicines. The performance of oral films depends on the selection of suitable film-forming polymers, plasticizers, active pharmaceutical ingredients (APIs), sweeteners, flavouring agents and other functional excipients. The solvent-casting method is widely discussed in the literature because of its simplicity and suitability for laboratory-scale development, while hot-melt extrusion, printing and other manufacturing approaches offer alternative opportunities. Evaluation involves physical appearance, thickness, weight variation, folding endurance, mechanical strength, surface pH, drug content uniformity, disintegration, dissolution and stability. Recent developments include improved taste-masking systems, natural polymer-based films, nanotechnology-assisted formulations, quality-by-design approaches and three-dimensional printing. However, challenges involving drug loading, moisture sensitivity, dose uniformity, scale-up and long-term stability remain important. This review examines the formulation principles, preparation methods, quality evaluation and emerging developments of fast-dissolving oral films, with particular emphasis on the comparative roles of natural and synthetic polymers. The review also identifies opportunities for further research in developing patient-friendly, stable and reproducible oral film formulations.
No takes yet. Share an insight, caveat, or question.
Janrao et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: